DeFer-2
Based on 1 Customer Validation
DeFer-2 is a ferritin PROTAC degrader (Kd = 17.1 μM). DeFer-2 induces ferritin degradation, triggering caspase 3-GSDME-mediated pyroptosis in cancer cells through free iron accumulation and elevated ROS. DeFer-2 significantly inhibits tumor growth and prolongs survival in mice bearing B16F10 subcutaneous tumors. DeFer-2 can be used to study melanoma.
(Pink: Ferritin ligand (HY-N1446); Blue: VHL ligand (HY-125845); Black: linker (HY-N0067)).
For research use only. We do not sell to patients.
- Purity: 98.25%
- CAS No.: 3058911-16-0
- Formula: C44H69N5O5S
- Molecular Weight:780.11
-
Storage:
-20°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Biological Activity
|
VHL |
Caspase 3 |
DeFer-2 (0-5 μM, 0-24 h) reduces the ferritin expression by forming a ternary complex with ferritin and VHL, induces disruption of redox and mitochondrial homeostasis in B16F10 cells[1].
DeFer-2 (5 μM, 8-24 h) initiates caspase 3-GSDME-mediated pyroptosis through free iron accumulation and ROS elevation in B16F10 cells[1].
DeFer-2 (24-48 h) causes severe cytotoxicity to B16F10 cells with IC50s of 3.1 and 1.5 μM for 24 and 48 h, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:B16F10 cells
-
Concentration:0, 0.008, 0.04, 0.2, 0.5, 1, 5 μM
-
Incubation Time:0 h, 4 h , 8 h, 12 h, 16 h, 24 h
-
Result:Reduced the ferritin expression.
Reduced the ferritin expression when as a nanoparticle albumin-DeFer-2.
-
Cell Line:B16F10 cells
-
Concentration:5 μM
-
Incubation Time:16 h
-
Result:Increased ROS levels.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:B16F10 tumor (1 × 106) mice (8-week-old, C57BL/6, male) model[1]
-
Dosage:10 mg/kg; in the form of nanoparticle albumin-DeFer-2
-
Administration:i.v., every other day, 8 days
-
Result:Inhibited tumor growth and prolonged survival time.
Did not cause systemic toxicity.
Chemical Information
-
CAS No. 3058911-16-0
-
Appearance Solid
-
Molecular Weight 780.11
-
Formula C44H69N5O5S
-
Color Off-white to light yellow
-
SMILES
CC1=C(SC=N1)C2=CC=C(C=C2)CNC([C@H](C[C@@H](O)C3)N3C([C@H](C(C)(C)C)NC(CCCNC(CCCCCCC/C=C\CCCCCCCC)=O)=O)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Solvent & Solubility
DMSO : 100 mg/mL (128.19 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (3.20 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (3.20 mM); Suspended solution
This protocol yields a suspended solution of ≥ 2.5 mg/mL (saturation unknown). Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.2819 mL | 6.4094 mL | 12.8187 mL | 32.0468 mL |
| 5 mM | 0.2564 mL | 1.2819 mL | 2.5637 mL | 6.4094 mL | |
| 10 mM | 0.1282 mL | 0.6409 mL | 1.2819 mL | 3.2047 mL | |
| 15 mM | 0.0855 mL | 0.4273 mL | 0.8546 mL | 2.1365 mL | |
| 20 mM | 0.0641 mL | 0.3205 mL | 0.6409 mL | 1.6023 mL | |
| 25 mM | 0.0513 mL | 0.2564 mL | 0.5127 mL | 1.2819 mL | |
| 30 mM | 0.0427 mL | 0.2136 mL | 0.4273 mL | 1.0682 mL | |
| 40 mM | 0.0320 mL | 0.1602 mL | 0.3205 mL | 0.8012 mL | |
| 50 mM | 0.0256 mL | 0.1282 mL | 0.2564 mL | 0.6409 mL | |
| 60 mM | 0.0214 mL | 0.1068 mL | 0.2136 mL | 0.5341 mL | |
| 80 mM | 0.0160 mL | 0.0801 mL | 0.1602 mL | 0.4006 mL | |
| 100 mM | 0.0128 mL | 0.0641 mL | 0.1282 mL | 0.3205 mL |